The association between PSCA gene polymorphism and hepatocellular carcinoma risk

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Hepatocellular carcinoma (HCC) remains a significant global health concern.
• Identifying genetic risk factors for HCC is crucial for early detection and prevention.
• Prostate stem cell antigen (PSCA) gene is a potential candidate for HCC susceptibility studies.

Purpose of the Study:

• To investigate the association between Prostate Stem Cell Antigen (PSCA) gene polymorphisms and the risk of developing hepatocellular carcinoma (HCC).
• To identify novel genetic markers for predicting HCC susceptibility.
• To establish an early warning system for individuals at risk of HCC.

Main Methods:

• A case-control study involving 160 HCC patients and 280 healthy controls.
• Genotyping of PSCA gene polymorphisms (rs2294008, rs2976392, rs1045531, rs2978974) using Polymerase Chain Reaction Restriction Fragment Length Polymorphism (PCR-RFLP).
• Analysis of the interaction between PSCA gene polymorphism and smoking status in relation to HCC risk.

Main Results:

• Significant associations were observed between PSCA gene polymorphisms at the rs2294008 and rs2976392 loci and an increased risk of HCC (P < 0.05).
• No significant associations were found for PSCA polymorphisms at the rs1045531 and rs2978974 loci (P > 0.05).
• No significant differences in genotype frequencies were observed between HCC patients who smoke and those who do not.

Conclusions:

• PSCA gene polymorphisms at rs2294008 and rs2976392 are confirmed risk factors for hepatocellular carcinoma.
• These specific PSCA polymorphisms represent novel biomarkers for predicting HCC risk.
• Further research may lead to improved early detection strategies for HCC based on these genetic markers.